Abstract
High-dose chemotherapy with peripheral blood stem cell (PBSC) transplantation in advanced germ cell tumour (GCT) patients is widely applied. The aims of this study were: (1) To examine the presence of alphafetoprotein (AFP) bearing tumour cells in PBSC harvests from advanced GCT patients obtained after multiple cycles of induction chemotherapy. (2) To determine whether induction chemotherapy contributed to in vivo purging of the tumour. We evaluated cryopreserved PBSC samples from 5 patients with advanced stage II/III AFP producing GCT. PBSC were separated after the first, second and third cycles of induction chemotherapy. Those samples were analysed using the nested reverse transcription polymerase chain reaction (RT-PCR) method to detect AFP mRNA. Although, in all patients, AFP mRNA was detected in PBSC samples after the first or second cycle of induction chemotherapy, but was not detected in 3 of 4 samples after the third cycle of chemotherapy. Although it is not clear whether tumour cells contaminating PBSC fraction contribute to disease relapse, PBSC harvested after at least 3 cycles of induction chemotherapy might be recommended to avoid such a possibility. © 2001 Cancer Research Campaign http://www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Armitage JO (1994) Bone marrow transplantation. N Engl J Med 330: 827–837
Beyer J, Kingreen D, Krause M, Schleicher J, Schwaner I, Schwella N, Huhn D and Siegert W (1997) Long-term survival of patients with recurrent or refractory germ cell tumors after high dose chemotherapy. Cancer 79: 161–168
Bilim V, Kawasaki T, Takahashi K and Tomita Y (1998) Absence of frameshift mutations in the bax gene in renal cell cancer (RCC) and transitional cell cancer (TCC). Anticancer Res 18: 1655–1660
Brenner MK, Rill DR, Moen RC, Krance RA, Mirro J Jr, Anderson WF and Ihle JN (1993) Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 341: 85–86
Broun ER, Nichols CR, Gize G, Cornetta K, Hromas RA, Schacht B and Einhorn LH (1997) Tandem high dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancer. Cancer 79: 1605–1610
Cooper BW, Moss TJ, Ross AA, Ybanez J and Lazarus HM (1998) Occult tumor contamination of hematopoietic stem-cell products does not affect clinical outcome of autologous transplantation in patients with metastatic breast cancer. J Clin Oncol 16: 3509–3517
Craig JI, Langlands K, Parker AC and Anthony RS (1994) Molecular detection of tumor contamination in peripheral blood stem cell harvests. Exp Hematol 22: 898–902
Elias AD, Ayash LJ, Wheeler C, Schwartz G, Tepler I, Gonin R, McCauley M, Mazanet R, Schinipper L and Frei E (1995) Phase I study of high dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support. Bone Marrow Transplant 15: 373–379
Fan Y, Einhorn L, Saxman S, Katz B, Abonour R and Cornetta K (1998) Detection of germ cell tumor cells in apheresis products using polymerase chain reaction. Clin Cancer Res 4: 93–98
Fields KK, Elfenbein GJ, Lazarus HM, Cooper BW, Perkins JB, Creger RJ, Ballester OF, Hiemenz JH, Janssen WE and Zorsky PE (1995) Maximum tolerated doses of ifosfamide, carboplatin, and etoposide given over 6 days followed by autologous stem-cell rescue: toxicity profile. J Clin Oncol 13: 323–332
Fields KK, Elfenbein GJ, Trudeau WL, Perkins JB, Janssen WE and Moscinski LC (1996) Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation. J Clin Oncol 14: 1868–1876
Ghossein RA, Bhattacharya S and Rosai J (1999) Molecular detection of micrometastases and circulating tumor cells in solid tumors. Clin Cancer Res 5: 1950–1960
Gribben JG, Freedman AS, Neuberg D, Roy DC, Blake KW, Woo SD, Grossbard ML, Rabinowe SN, Coral F and Freeman GJ (1991) Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Eng J Med 325: 1525–1533
Jiang SY, Shyu RY, Huang MF, Tang HS, Young TH, Roffler SR, Chiou YS and Yeh MY (1997) Detection of alphafetoprotein-expressing cells in the blood of patients with hepatoma and hepatitis. Br J Cancer 75: 928–933
Kennedy MJ, Vogelsang GB, Jones RJ, Farmer ER, Hess AD, Altomonte V, Huelskamp AM and Davidson NE (1994) Phase I trial of interferon gamma to potentiate cyclosporine-induced graft-versus host disease in women undergoing autologous bone marrow transplantation for breast cancer. J Clin Oncol 12: 249–257
Knowles BB, Howe CC and Aden DP (1980) Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 209: 497–499
Komeda T, Fukukda Y, Sando T, Kita R, Furukawa M, Nishida N, Amenomori M and Nakao K (1995) Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood. Cancer 75: 2214–2219
Mapara MY, Korner IJ, Hildebrandt M, Bargou R, Krahl D, Reichardt P and Dorken B (1997) Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: comparison of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain reaction. Blood 89: 337–344
Mattano LA Jr., Moss TJ and Emerson SG (1992) Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. Cancer Res 52: 4701–4705
Morinaga T, Sakai M, Wegmann TG and Tamaoki T (1983) Primary structures of human alpha-fetoprotein and its mRNA. Proc Natl Acad Sci USA 80: 4604–4608
Moss TJ, Sanders DG, Lasky LC and Bostrom B (1990) Contamination of peripheral blood stem cell harvests by circulating neuroblastoma cells. Blood 76: 1879–1883
Nichols CR, Anderson J, Lazarus HM, Fisher H, Greer J, Stadtmauer EA, Loehrer PJ and Trump DL (1992) High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol. J Clin Oncol 10: 558–563
Passos-Coelho JL, Ross AA, Kahn DJ, Moss TJ, Davis JM, Huelskamp AM, Noga SJ, Davidson NE and Kennedy MJ (1996) Similar breast cancer cell contamination of single-day peripheral-blood progenitor-cell collections obtained after priming with hematopoietic growth factor alone or after cyclophosphamide followed by growth factor. J Clin Oncol 14: 2569–2575
Rill DR, Santana VM, Roberts WM, Nilson T, Bowman LC, Krance RA, Heslop HE, Moen RC, Ihle JN and Brenner MK (1994) Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 84: 380–383
Schulze R, Schulze M, Wischnik A, Ehnle S, Doukas K, Behr W, Ehret W and Schlimok G (1997) Tumor cell contamination of peripheral blood stem cell transplants and bone marrow in high-risk breast cancer patients. Bone Marrow Transplant 19: 1223–1228
Spyridonidis A, Schmidt M, Bernhardt W, Papadimitriou A, Azemar M, Wels W, Groner B and Henschler R (1998) Purging of mammary carcinoma cells during ex vivo culture of CD34+ hematopoietic progenitor cells with recombinant immunotoxins. Blood 91: 1820–1827
Vannucchi AM, Bosi A, Glinz S, Pacini P, Linari S, Saccardi R, Alterini R, Rigacci L, Guidi S, Lombardini L, Longo G, Mariani MP and Rossi-Ferrini P (1998) Evaluation of breast tumour cell contamination in the bone marrow and leukapheresis collections by RT-PCR for cytokeratin-19 mRNA. Br J Haematol 103: 610–617
Vogel W, Behringer D, Scheding S, Kanz L and Brugger W (1996) Ex vivo expansion of CD34+ peripheral blood progenitor cells: implications for the expansion of contaminating epithelial tumor cells. Blood 88: 2707–2713
Vredenburgh JJ, Silva O, Broadwater G, Berry D, DeSombre K, Tyer C, Petros WP, Peters WP and Bast RC, Jr. (1997) The significance of tumor contamination in the bone marrow from high-risk primary breast cancer patients treated with high-dose chemotherapy and hematopoietic support. Biol Blood Marrow Transplant 3: 91–97
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Kasahara, T., Hara, N., Bilim, V. et al. Sequential detection of alphafetoprotein-bearing cells in blood stem cell fraction of germ cell tumour patients. Br J Cancer 85, 1119–1123 (2001). https://doi.org/10.1054/bjoc.2001.2050
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.2050
Keywords
This article is cited by
-
Viral purging of haematological autografts: should we sneeze on the graft?
Bone Marrow Transplantation (2007)
-
Cryopreserved Human B Cells as an Alternative Source for Single Cell mRNA Analysis
Cell and Tissue Banking (2005)